The cause of persistent arthritis in patients with Lyme disease who have received standard antibiotic therapy remains an area of debate. In this study, synovial fluid levels of matrix metalloproteinases (MMPs) were compared in persons with untreated and antibiotic-resistant Lyme arthritis. Levels of MMP-1 and MMP-3, as determined by ELISA, were higher in untreated patients ( and , respectively), whereas levels of MMP-8 and P p .0064 P p .002 MMP-9 were higher in antibiotic-resistant patients ( and , respectively). 
or antibiotic-resistant Lyme arthritis. In septic arthritis caused by bacteria, such as Staphylococcus aureus, a combination of bacterial proteases and host proteases from inflammatory cells leads to rapid destruction of articular cartilage. In contrast, both untreated and antibiotic-resistant Lyme arthritis are slowly progressing processes, in which synovial fluid studies typically reveal only moderate elevations of inflammatory cells [3] . There has been a single report that stated that lysates of B. burgdorferi possess a collagenolytic enzyme 1200 kDa [7] . However, we and others have found that B. burgdorferi does not secrete any enzymes capable of digesting collagen, laminin, or gelatin [8, 9] . In addition, a search of the B. burgdorferi genome showed no genes with significant identity to those of other bacterial collagenases [10] .
Matrix metalloproteinases (MMPs) are enzymes produced by host cells that are capable of digesting many of the components of cartilage tissue [11] . They have been implicated in the pathogenesis of other slowly progressive arthritides, such as rheumatoid arthritis and osteoarthritis [12] [13] [14] [15] . We showed elsewhere that the presence of B. burgdorferi can cause degradation of cartilage explants, as measured by release of glycosaminoglycans and hydroxy-proline from cartilage explants [16] . This breakdown is inhibited by batimastat, a specific inhibitor of MMPs, which confirms the role of MMPs in B. burgdorferiinduced cartilage degradation. Here we present data on the individual MMPs found in the synovial fluid of patients with untreated and antibiotic-resistant Lyme arthritis.
Patients and Methods
Patients. Synovial fluid was obtained from 18 patients with untreated Lyme arthritis (ULA) and 15 patients with persistent Downloaded from https://academic.oup.com/jid/article-abstract/184/2/174/1055648 by guest on 08 April 2019 Lyme arthritis (PLA) after antibiotic therapy. All patients were infected in the northeastern United States and had oligoarticular arthritis involving 1 or both knees. All patients in both groups met the Centers for Disease Control and Prevention (CDC) clinical criteria for the diagnosis of Lyme disease. They had monoarticular or oligoarticular arthritis affecting у1 knee that was accompanied by a positive IgG Western blot test for Lyme disease, which was interpreted according to CDC/Association of State and Territorial Public Health Laboratory Directors criteria [17] .
All 18 ULA patients had positive polymerase chain reaction (PCR) results for B. burgdorferi DNA in synovial fluid (done as described in [18] ). All specimens were aliquoted and were stored at Ϫ70ЊC until use.
Infection of cell cultures with B. burgdorferi. Primary human chondrocyte cultures from a healthy donor and primary human synoviocyte cultures from a patient with rheumatoid arthritis were obtained from Cell Applications. Cells were grown to confluence in 6-well trays in either chondrocyte or synoviocyte culture media (Cell Applications) containing 10% fetal calf serum (FCS). At 24 h before infection with B. burgdorferi, the culture medium was changed to either chondrocyte or synoviocyte culture medium without FCS. Low-passage (passage 4-8) B. burgdorferi strain N40 was cultured in Barbour-Stoenner-Kelly (BSK) medium, as described elsewhere [19, 20] . Spirochetes were centrifuged, washed 3 times, resuspended in cell culture medium, and added to cultures (10 7 organisms) in a final volume of 1 mL of chondrocyte or synoviocyte culture medium without FCS. Cultures were incubated for 5 days at 37ЊC in 5% CO 2 . Removed media were aliquoted and were stored at Ϫ70ЊC until use.
For experiments with killed bacteria, 10 7 B. burgdorferi (N40) or S. aureus were sonicated for 2.5 min (Branson Sonifier 450) or were heated at 100ЊC for 10 min and added to cell cultures, as described above. Lipidated outer surface protein (Osp) A of B. burgdorferi was generated as a recombinant fusion protein to maltose-binding protein, as described elsewhere [21] .
MMP assays. Sandwich ELISAs for MMP-1, MMP-3, MMP-8, and MMP-9 were obtained from Oncogene Research and were done according to the manufacturer's instructions. All samples were run in duplicate. Samples that showed intra-assay variability 110% were repeated. Selected samples were tested in 3 separate experiments to verify interexperiment reliability. Variability between experiments was !10%. For calculation purposes, samples that fell below the limit of detection were assigned values at the limit of detection. Gelatinolytic zymography also was performed to assess levels of MMP-2 and MMP-9: 0.1 mL of synovial fluid was subjected to zymography in 7.5% polyacrylamide gels containing 0.1% gelatin as a substrate, as described elsewhere [22] .
Reverse-transcriptase (RT) PCR. Total RNA was obtained from cells by use of RNeasy (Qiagen), according to the manufacturer's instructions. DNaseI (Gibco) was added to the preparation to remove any DNA contamination. RT-PCR was performed by using Superscript (Gibco), according to the manufacturer's instructions. Primers for CD14 (5 -AGACTTATCGACCATTGAGC-3 and 5 -GCCTACCAGTAGCTGAGCAG-3 ) [23] , TLR-2 (5 -AC-TTTGTGGATGGTGTGGGTCTTGG-3 and 5 -AGATGTTTC-CCCTAGGGTTTTGTAAGGA-3 ), and TLR-4 (5 -TACAAAA-TCCCCGACAACCTCCCCT-3 and 5 -AACGATGGACTTCT-AAACCAGCCAGA-3 ) produced predicted products of 333, 420, and 637 bp, respectively. PCR products were electrophoresed on 1% agarose gels. Quantitative comparison of bands was done by using scanning densitometry.
Results

Comparison of synovial fluid MMPs in patients with
ULA and antibiotic-resistant PLA. We examined synovial fluid from 18 patients with ULA and from 15 patients with PLA for the presence of MMP-1, MMP-2, MMP-3, MMP-8, and MMP-9, using ELISA or gelatinolytic zymography. Because there is minimal synovial fluid in healthy joints, comparison with normal synovial fluid could not be made. All patients with ULA had evidence of B. burgdorferi in their synovial fluid, as determined by PCR, for the OspA gene of B. burgdorferi. All patients with PLA were negative for B. burgdorferi DNA, using PCR. By using ELISA, we found that levels of MMP-1 and MMP-3 were significantly elevated in patients with ULA, compared with those in patients with PLA (figure 1). Levels of MMP-8 and MMP-9 were reversed, with significantly higher levels in the synovial fluid of patients with PLA than that of patients with ULA. In fact, the data for MMP-9 underestimate the true difference between the groups, because 13 of the 18 ULA samples fell below the level of detection of the assay and were assigned values at the level of detection (0.15 mg/mL) for calculation. Levels of MMP-2 and MMP-9 also were determined by gelatinolytic zymography. Densitometry measurements from zymograms for MMP-9 were comparable with ELISA results. No significant differences in levels of synovial fluid MMP-2 were seen between the groups (data not shown).
WBC counts and synovial fluid MMP levels. One possible source of MMPs in the synovial fluid of these patients is inflammatory cells. We had data for synovial fluid WBC counts for 17 samples from patients with ULA and for 10 samples from patients with PLA. Although the patients with ULA generally had a higher WBC count than did the patients with PLA (mean, 24,900 and 13,200 cells/mL, respectively), this did not reach significance (
). There was no correlation between P p .072 WBC counts and levels of MMP-1, MMP-3, or MMP-8 in patients with ULA or of MMP-1 and MMP-3 in patients with PLA. Values for MMP-9 in patients with ULA were too low for meaningful analysis, as only 4 values were above the limit of detection. WBC counts did correlate with levels of MMP-8 and MMP-9 in patients with PLA. The correlation coefficient Characterization of MMP-1 and MMP-3 induction from chondrocytes. We next sought to test whether the response of chondrocytes to B. burgdorferi is dependent on the viability of the spirochetes. We have found that B. burgdorferi grown in coculture with chondrocytes in cell culture medium remain viable for up to 1 week (i.e., can be recultured in BSK medium), although they will not grow or multiply in this medium. We added heat-killed and sonicated B. burgdorferi to chondrocyte cultures. Both heat-killed and sonicated spirochetes were capable of inducing MMP-1, although the response to heat-killed spirochetes was diminished (figure 4). Sonicated, but not heatkilled, B. burgdorferi were capable of inducing MMP-3 from chondrocytes. The B. burgdorferi lipoprotein OspA also was capable of inducing MMP-1 and MMP-3 release in a doserelated pattern. In contrast, sonicated S. aureus was incapable of inducing MMP-1 or MMP-3 from chondrocytes. Live S. aureus could not be studied because it grew rapidly in the culture medium, resulting in death of the chondrocytes.
CD14 and toll-like receptor (TLR) expression by chondrocytes.
Reports by other investigators have suggested a role for CD14 and TLR-2 in cellular response to B. burgdorferi [24] [25] [26] . It appears that B. burgdorferi lipoproteins bind to CD14, which then interact with TLR-2 to signal for cellular activation [27] . We reported elsewhere that soluble (s) CD14 levels are increased in patients with untreated Lyme disease [28] . We examined expression of CD14, TLR-2, and the LPS receptor, TLR-4, by using semiquantitative RT-PCR. By using this method, we found that CD14 mRNA is transcribed by both chondrocytes and synoviocytes (figure 5A). Transcription of CD14 mRNA is minimally increased (∼2-3-fold) from chondrocytes in the presence of B. burgdorferi, as measured by scanning densitometry of the amplicons. sCD14 measured by ELISA in chondrocyte culture supernatants was increased 2- fold in the presence of B. burgdorferi. Neither CD14 mRNA transcription nor sCD14 in culture supernatants was increased in synoviocyte cultures in the presence of B. burgdorferi. TLR-2 is expressed by chondrocytes, and expression is increased 123-fold in the presence of B. burgdorferi ( figure 5B ). In contrast, we did not find expression of TLR-2 in our synoviocyte line. TLR-4 expression in both chondrocyte and synoviocyte cultures was low to undetectable, as determined by RT-PCR, and not augmented by the addition of TNF-a, LPS, or B. burgdorferi. Control reactions in the absence of RT or cDNA did not show any amplicons for any of the experiments (data not shown).
Discussion
The pathways involved in the development of Lyme arthritis are just beginning to be explored. In this study, we found significant differences in the MMPs present in the synovial fluid of patients with ULA and PLA. Increases in synovial fluid MMP-1 and MMP-3 in patients with ULA, who have detectable B. burgdorferi DNA in their synovial fluid, are paralleled by the ability of the organism to induce these MMPs from chondrocytes in culture. B. burgdorferi are not capable of inducing MMP-8 or MMP-9, which are higher in PLA patients, from either synoviocytes or chondrocytes. The significant cor- relation between synovial fluid WBC counts and MMP-8 and MMP-9 levels suggests that inflammatory cells might be responsible, either directly or through secretion of inflammatory cytokines, and might act on intrinsic joint cells for higher levels of these MMPs in patients with PLA.
Differences in MMPs found in the synovial fluid of patients with ULA and PLA are consistent with separate mechanisms of induction. Our data suggest that the synovial fluid MMP response in patients with ULA probably is mediated through the innate immune system. Recent studies show that monocytes are activated by B. burgdorferi through the interaction of borrelial lipoproteins with the surface marker CD14 in a manner analogous to the immune response to LPS [24] [25] [26] . The lipoprotein-CD14 complex then interacts with TLR-2 to signal cellular activation and release of inflammatory mediators [27] .
Chondrocytes display many functional properties in common with cells of monocyte/macrophage lineage, including production of immunoregulatory cytokines, release of reactive oxygen intermediates, stimulation of autologous and allogenic mixed leukocyte reactions, and the ability to function as antigen-presenting cells [29] [30] [31] [32] [33] [34] . Chondrocytes also share expression of many surface antigens with monocytes and/or macrophages [23] . Our findings that CD14 and TLR-2 transcriptions in chondrocytes are increased in the presence of B. burgdorferi are consistent with a role for this system in MMP induction. Recognition of B. burgdorferi lipoproteins by the CD14-TLR-2 system is lost with deacylation and loss of lipid attachment [25, 27, 35] . The lack of MMP induction from chondrocytes by S. aureus furthers the concept that there is specificity in the recognition of B. burgdorferi and its products and in the subsequent development of chronic arthritis. The minimal expression of the LPS receptor TLR-4 on our cell lines is consistent with the lack of MMP response to LPS from chondrocytes and synoviocytes. S. aureus and LPS containing gram-negative bacteria cause acute arthritis characterized by rapid destruction of the joint through secretion of bacterial proteases and activation of WBC counts. The clinical and histologic development of ULA, with its slow progression to erosive arthritis, is more consistent with chronic arthritides, such as rheumatoid arthritis or osteoarthritis, in which the induction of MMPs from joint tissue is thought to play an important role.
In contrast, PLA does not typically result in radiographically apparent joint erosions, even after longstanding disease (authors' unpublished data). One possible explanation for this difference in phenotype is the difference in synovial fluid MMPs. Our data suggest that the stimulus for MMP induction in PLA is unlikely to be mediated through the innate immune response to B. burgdorferi in intrinsic joint cells. B. burgdorferi is not typically detectable in the synovial fluid of patients with arthritis after antibiotic therapy [36] . In the absence of borrelial lipoproteins in the joint, the activation of the innate immune response does not occur. Furthermore, the MMPs elevated in the synovial fluid of patients with PLA are not induced from chondrocytes or synoviocytes by B. burgdorferi.
One hypothesis to account for the ongoing joint inflammation is that, in a small percentage of genetically susceptible patients, there is inappropriate persistence of the antigen-specific response after antibiotic therapy. Gross et al. [6] found evidence for molecular mimicry between a dominant epitope of OspA and lymphocyte function-associated antigen-1 in patients with post-antibiotic treatment Lyme arthritis, suggesting an autoimmune pathogenesis of arthritis in these patients. The presence of a population of activated autoreactive T cells in the synovial fluid of PLA patients could explain the higher levels of MMP-8 and MMP-9, despite overall lower WBC counts, than in ULA patients. The signaling pathway by which molecular mimicry can lead to induction of MMP-8 and MMP-9 remains to be determined.
An understanding of the role of individual MMPs in the development of either ULA or PLA will require further study. Our in vitro studies do not address the impact of the various human MMP activators and inhibitors that may be coinduced by B. burgdorferi or the impact of the maturational stage of the cells and the complex cell-to-cell interactions that affect the induction of MMPs. However, the evidence for differences in the pathway to induction of these MMPs has important implications in the treatment of patients with these diseases. Patients with "chronic" Lyme disease continue to be treated with prolonged courses of antibiotics. Prolonged antibiotic therapy exposes patients to many risks, including adverse drug reactions, infections with resistant microorganisms, catheter-related infections, and, as recently reported for a patient receiving longterm therapy for chronic Lyme disease, even death [37] . Our study results argue that PLA should not be treated as a persistent B. burgdorferi infection. Understanding the basis for arthritis in PLA may lead to the development of more specific anti-inflammatory-based therapies for patients with persistent posttreatment disease.
